Recommanded Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Acta Pharmaceutica Sinica. B | Isoalantolactone induces AML cell pyroptosis by targeting TXNRD1 and enhances anti-PD-1 efficacy
2026-05-13
【Frontier Express】Cell Death and Differentiation | Dural Treg Cells Alleviate Depression via EGFR Signaling Pathway in mPFC Neurons
2026-05-12
【Frontier Express】Cancer Discovery | BBO-11818: A Non-covalent Pan-KRAS Inhibitor Targeting Both ON and OFF States of Mutant KRAS
2026-05-11
【Frontier Express】Journal of Clinical Oncology | A Phase 2 Study of PD-1 and VEGF Dual-Target Combination Therapy for Melanoma Brain Metastases
2026-05-11
【Frontier Express】Signal Transduction and Targeted Therapy | Long-term survival outcomes of patients with advanced hepatocellular carcinoma receiving surgery after conversion therapy with PD-1 inhibitor plus lenvatinib
2026-05-10
【Frontier Express】Nature Communications | Efficacy and Biomarker Study of Durvalumab, Cediranib, and Olaparib Combination Therapy in Recurrent Ovarian Cancer
2026-05-10
【Frontier Express】iMeta | Single-Cell Transcriptomics Reveals Heterogeneity and Phenotypic Transitions of Smooth Muscle Cells in Aortic Dissection
2026-05-09






